domingo, 27 de marzo de 2011

FDA clears first melanoma drug to extend life

The Food and Drug Administration has approved a breakthrough cancer medication from Bristol-Myers Squibb Co. that researchers have heralded as the first drug shown to prolong the lives of patients with advanced skin cancer.


No hay comentarios: